scholarly journals Postconditioning with Sevoflurane or Propofol Alleviate Lipopolysaccharide-Induced Neuroinflammation, but Exert Dissimilar Effects on NR2B Subunit and Cognition

Author(s):  
Hongliang Liu ◽  
Bo Chen ◽  
Bianqin Guo ◽  
Xiaoyuan Deng ◽  
Bin Wang ◽  
...  

Abstract Neuroinflammation can cause cognitive deficits, and pre-existing neuroinflammation is very common in the clinic after trauma, surgery, and infection. Patients with pre-existing neuroinflammation often need further medical treatment under general anesthesia. However, it is still unknown the effects of postconditioning with general anesthetics on the pre-existing neuroinflammation. In this study, adult rats were post-treated with sevoflurane or propofol after intracerebroventricular administration of lipopolysaccharide. The effects of sevoflurane or propofol postconditioning on neuroinflammation-induced recognition memory deficit were detected. Our results found that postconditioning with sevoflurane, but not propofol reversed the selective spatial recognition memory impairment induced by neuroinflammation, and these differential effects did not appear to be associated with the similar anti-neuroinflammatory response of general anesthetics. However, postconditioning with propofol induced a selective long-lasting upregulation of extrasynaptic NR2B-containing NMDARs in the dorsal hippocampus, which down-regulated the CREB signaling pathway, and impaired spatial recognition memory. Additionally, the NR2B antagonists, memantine and Ro2506981, reversed this neurotoxicity induced by propofol postconditioning. Altogether, these results indicate that under the pre-existing neuroinflammation, postconditioning with sevoflurane can provide reliable neuroprotection through attenuating LPS-induced neuroinflammation, apoptosis, neuronal loss, and eventually improving spatial recognition deficit. However, although posttreatment with propofol also have the same anti-neuroinflammatory effects, the neurotoxicity caused by propofol postconditioning following neuroinflammation deserves to be continuously concerned.

2020 ◽  
Vol 24 (12) ◽  
pp. 7000-7014
Author(s):  
Xu‐Jia Zeng ◽  
Ping Li ◽  
Ya‐Lei Ning ◽  
Yan Zhao ◽  
Yan Peng ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Sarah-Jane Leigh ◽  
Nadeem O. Kaakoush ◽  
Michael J. Bertoldo ◽  
R. Frederick Westbrook ◽  
Margaret J. Morris

2009 ◽  
Vol 169 (1) ◽  
pp. 39-42 ◽  
Author(s):  
David Luck ◽  
Alonso Montoya ◽  
Matthew Menear ◽  
Amélie M. Achim ◽  
Samarthji Lal ◽  
...  

2021 ◽  
pp. 105832
Author(s):  
Masahito Sawahata ◽  
Hiroki Asano ◽  
Taku Nagai ◽  
Norimichi Ito ◽  
Takao Kohno ◽  
...  

2017 ◽  
Vol 55 (1) ◽  
pp. 26-41 ◽  
Author(s):  
Ane Murueta-Goyena ◽  
Naiara Ortuzar ◽  
Pascual Ángel Gargiulo ◽  
José Vicente Lafuente ◽  
Harkaitz Bengoetxea

2017 ◽  
Vol 118 (1) ◽  
pp. 194-202 ◽  
Author(s):  
Joseph W. Salatino ◽  
Bailey M. Winter ◽  
Matthew H. Drazin ◽  
Erin K. Purcell

Microelectrode arrays implanted in the brain are increasingly used for the research and treatment of intractable neurological disease. However, local neuronal loss and glial encapsulation are known to interfere with effective integration and communication between implanted devices and brain tissue, where these observations are typically based on assessments of broad neuronal and astroglial markers. However, both neurons and astrocytes comprise heterogeneous cellular populations that can be further divided into subclasses based on unique functional and morphological characteristics. In this study, we investigated whether or not device insertion causes alterations in specific subtypes of these cells. We assessed the expression of both excitatory and inhibitory markers of neurotransmission (vesicular glutamate and GABA transporters, VGLUT1 and VGAT, respectively) surrounding single-shank Michigan-style microelectrode arrays implanted in the motor cortex of adult rats by use of quantitative immunohistochemistry. We found a pronounced shift from significantly elevated VGLUT1 within the initial days following implantation to relatively heightened VGAT by the end of the 4-wk observation period. Unexpectedly, we observed VGAT positivity in a subset of reactive astrocytes during the first week of implantation, indicating heterogeneity in early-responding encapsulating glial cells. We coupled our VGLUT1 data with the evaluation of a second marker of excitatory neurons (CamKiiα); the results closely paralleled each other and underscored a progression from initially heightened to subsequently weakened excitatory tone in the neural tissue proximal to the implanted electrode interface (within 40 μm). Our results provide new evidence for subtype-specific remodeling surrounding brain implants that inform observations of suboptimal integration and performance. NEW & NOTEWORTHY We report novel changes in the local expression of excitatory and inhibitory synaptic markers surrounding microelectrode arrays implanted in the motor cortex of rats, where a progressive shift toward increased inhibitory tone was observed over the 4-wk observation period. The result was driven by declining glutamate transporter expression (VGLUT1) in parallel with increasing GABA transporter expression (VGAT) over time, where a reactive VGAT+ astroglial subtype made an unexpected contribution to our findings.


Sign in / Sign up

Export Citation Format

Share Document